Upgrades
According to B of A Securities, the prior rating for Ameresco Inc (NYSE:AMRC) was changed from Neutral to Buy. For the second quarter, Ameresco had an EPS of $0.62, compared to year-ago quarter EPS of $0.34. The stock has a 52-week-high of $86.73 and a 52-week-low of $40.73. At the end of the last trading period, Ameresco closed at $65.02.
Loop Capital upgraded the previous rating for Adtran Inc (NASDAQ:ADTN) from Hold to Buy. For the second quarter, Adtran had an EPS of $0.19, compared to year-ago quarter EPS of $0.16. The stock has a 52-week-high of $25.47 and a 52-week-low of $16.30. At the end of the last trading period, Adtran closed at $18.11.
According to Scotiabank, the prior rating for Methanex Corp (NASDAQ:MEOH) was changed from Sector Perform to Sector Outperform. In the second quarter, Methanex showed an EPS of $1.16, compared to $1.24 from the year-ago quarter. The stock has a 52-week-high of $56.79 and a 52-week-low of $28.73. At the end of the last trading period, Methanex closed at $28.97.
According to Needham, the prior rating for Chegg Inc (NYSE:CHGG) was changed from Hold to Buy. Chegg earned $0.37 in the second quarter, compared to $0.43 in the year-ago quarter. At the moment, the stock has a 52-week-high of $37.64 and a 52-week-low of $15.66. Chegg closed at $18.95 at the end of the last trading period.
Morgan Stanley upgraded the previous rating for Helmerich & Payne Inc (NYSE:HP) from Underweight to Equal-Weight. In the third quarter, Helmerich & Payne showed an EPS of $0.27, compared to $0.57 from the year-ago quarter. At the moment, the stock has a 52-week-high of $54.59 and a 52-week-low of $23.83. Helmerich & Payne closed at $35.48 at the end of the last trading period.
According to Raymond James, the prior rating for Planet Fitness Inc (NYSE:PLNT) was changed from Market Perform to Strong Buy. For the second quarter, Planet Fitness had an EPS of $0.38, compared to year-ago quarter EPS of $0.21. The current stock performance of Planet Fitness shows a 52-week-high of $97.33 and a 52-week-low of $54.15. Moreover, at the end of the last trading period, the closing price was at $55.88.
See all analyst ratings upgrades.
Downgrades
SMBC Nikko downgraded the previous rating for DLocal Ltd (NASDAQ:DLO) from Neutral to Underperform. DLocal earned $0.10 in the second quarter, compared to $0.07 in the year-ago quarter. The current stock performance of DLocal shows a 52-week-high of $36.88 and a 52-week-low of $15.19. Moreover, at the end of the last trading period, the closing price was at $22.62.
For Paymentus Holdings Inc (NYSE:PAY), SMBC Nikko downgraded the previous rating of Outperform to Neutral. In the second quarter, Paymentus Holdings showed an EPS of $0.00, compared to $0.02 from the year-ago quarter. The stock has a 52-week-high of $35.00 and a 52-week-low of $9.39. At the end of the last trading period, Paymentus Holdings closed at $9.68.
UBS downgraded the previous rating for Lyft Inc (NASDAQ:LYFT) from Buy to Neutral. For the second quarter, Lyft had an EPS of $0.13, compared to year-ago quarter EPS of $0.05. The current stock performance of Lyft shows a 52-week-high of $46.64 and a 52-week-low of $11.96. Moreover, at the end of the last trading period, the closing price was at $13.99.
Morgan Stanley downgraded the previous rating for NexTier Oilfield Solutions Inc (NYSE:NEX) from Overweight to Equal-Weight. For the second quarter, NexTier Oilfield had an EPS of $0.39, compared to year-ago quarter EPS of $0.19. At the moment, the stock has a 52-week-high of $12.50 and a 52-week-low of $3.56. NexTier Oilfield closed at $6.88 at the end of the last trading period.
Morgan Stanley downgraded the previous rating for Core Laboratories NV (NYSE:CLB) from Equal-Weight to Underweight. For the second quarter, Core Laboratories had an EPS of $0.12, compared to year-ago quarter EPS of $0.17. At the moment, the stock has a 52-week-high of $35.83 and a 52-week-low of $13.75. Core Laboratories closed at $13.91 at the end of the last trading period.
For Immunovant Inc (NASDAQ:IMVT), UBS downgraded the previous rating of Buy to Neutral. For the first quarter, Immunovant had an EPS of $0.35, compared to year-ago quarter EPS of $0.31. The current stock performance of Immunovant shows a 52-week-high of $8.87 and a 52-week-low of $3.15. Moreover, at the end of the last trading period, the closing price was at $4.88.
Jefferies downgraded the previous rating for Safe Bulkers Inc (NYSE:SB) from Buy to Hold. Safe Bulkers earned $0.40 in the second quarter, compared to $0.31 in the year-ago quarter. At the moment, the stock has a 52-week-high of $5.12 and a 52-week-low of $2.70. Safe Bulkers closed at $2.77 at the end of the last trading period.
For Golden Ocean Group Ltd (NASDAQ:GOGL), Jefferies downgraded the previous rating of Buy to Hold. Golden Ocean Group earned $0.81 in the second quarter, compared to $0.52 in the year-ago quarter. The current stock performance of Golden Ocean Group shows a 52-week-high of $16.46 and a 52-week-low of $7.62. Moreover, at the end of the last trading period, the closing price was at $8.28.
For Diana Shipping Inc (NYSE:DSX), Jefferies downgraded the previous rating of Buy to Hold. Diana Shipping earned $0.42 in the second quarter, compared to $0.02 in the year-ago quarter. The stock has a 52-week-high of $6.89 and a 52-week-low of $3.31. At the end of the last trading period, Diana Shipping closed at $4.22.
For Sotera Health Co (NASDAQ:SHC), Keybanc downgraded the previous rating of Overweight to Sector Weight. Sotera Health earned $0.27 in the second quarter, compared to $0.26 in the year-ago quarter. The current stock performance of Sotera Health shows a 52-week-high of $24.90 and a 52-week-low of $7.08. Moreover, at the end of the last trading period, the closing price was at $7.34.
See all analyst ratings downgrades.
Initiations
With an Overweight rating, Capital One initiated coverage on Executive Network Partnering Corp (NYSE:ENPC). The price target seems to have been set at $13.00 for Executive Network.
Wells Fargo initiated coverage on Neurocrine Biosciences Inc (NASDAQ:NBIX) with a Equal-Weight rating. The price target for Neurocrine Biosciences is set to $110.00. Neurocrine Biosciences earned $0.84 in the second quarter, compared to $0.63 in the year-ago quarter. The stock has a 52-week-high of $109.26 and a 52-week-low of $71.88. At the end of the last trading period, Neurocrine Biosciences closed at $103.50.
With an Overweight rating, Wells Fargo initiated coverage on Cerevel Therapeutics Holdings Inc (NASDAQ:CERE). The price target seems to have been set at $38.00 for Cerevel Therapeutics Hldg. In the second quarter, Cerevel Therapeutics Hldg showed an EPS of $0.61, compared to $0.42 from the year-ago quarter. The current stock performance of Cerevel Therapeutics Hldg shows a 52-week-high of $41.46 and a 52-week-low of $19.86. Moreover, at the end of the last trading period, the closing price was at $26.21.
With a Buy rating, EF Hutton initiated coverage on American Rebel Holdings Inc (NASDAQ:AREB). The price target seems to have been set at $1.50 for American Rebel Holdings. For the second quarter, American Rebel Holdings had an EPS of $0.34, compared to year-ago quarter EPS of $2.15. The current stock performance of American Rebel Holdings shows a 52-week-high of $4.20 and a 52-week-low of $0.03. Moreover, at the end of the last trading period, the closing price was at $0.35.
Citigroup initiated coverage on Farfetch Ltd (NYSE:FTCH) with a Sell rating. The price target for Farfetch is set to $6.00. In the second quarter, Farfetch showed an EPS of $0.21, compared to $0.17 from the year-ago quarter. The current stock performance of Farfetch shows a 52-week-high of $35.26 and a 52-week-low of $6.52. Moreover, at the end of the last trading period, the closing price was at $8.57.
Credit Suisse initiated coverage on Willis Towers Watson PLC (NASDAQ:WTW) with an Outperform rating. The price target for Willis Towers Watson is set to $288.00. In the second quarter, Willis Towers Watson showed an EPS of $2.32, compared to $2.12 from the year-ago quarter. At the moment, the stock has a 52-week-high of $244.73 and a 52-week-low of $187.89. Willis Towers Watson closed at $200.34 at the end of the last trading period.
